Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Newsletter out

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Oct 26, 2020 1:10pm

127 Views

Post# 31782042

RE:RE:Newsletter out

No new patients have been treated in Canada. With new covid cases at new peak levels in Canada and the US don't expect any new patients to be tested any time soon. At the most optimistic patient 25 might be treated December 2021, with the one year mark at December 2022 and results released sometime in early 2023. If you know who wins in the US expect the push for full lockdown until the virus is completely eradicated by which time a new virus will arrive to repeat the lockdown. Forget about any US trial.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects